Association of clot burden score with radiographic and clinical outcomes following Solitaire stent retriever thrombectomy

Analysis of the SWIFT PRIME trial

Maxim Mokin, Elad I. Levy, Adnan H. Siddiqui, Mayank Goyal, Raul G. Nogueira, Dileep R Yavagal, Vitor M. Pereira, Jeffrey L. Saver

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background The clot burden score (CBS) was developed as a tool to evaluate the extent of intracranial thrombus burden in patients with anterior circulation acute ischemic stroke. CBS is based on the presence or absence of contrast opacification on CT angiography (CTA). Its value in predicting radiographic and clinical outcomes in patients given endovascular stroke therapy remains unknown. Objective To evaluate the relationship between CBS and outcomes after stent retriever thrombectomy in the interventional arm of the SWIFT PRIME trial. Methods CBS was calculated for the endovascular arm (IV tissue plasminogen activator plus Solitaire stent retriever) of SWIFT PRIME using baseline CTA. The cohort of 69 patients was divided into three groups according to their CBS values: CBS 0-5 (n=14), CBS 6-7 (n=23), and CBS 8-9 (n=32). Results The mean age of the 69 patients who formed the study cohort was 63.2-13.1 years, mean National Institutes of Health Stroke Scale score was 16.8-4.5, and 55% of the patients were male. There was no difference in clinical characteristics among the three groups, except for the baseline Alberta Stroke Program Early CT Score (p=0.049). The site of proximal occlusion varied significantly among the three groups ( p0.001). Rates of successful recanalization (TICI 2b/3), complete recanalization (TICI 3 only) and of good clinical outcome at 3 months were similar among the three groups (p=0.24, p=0.35, and p=0.52, respectively). Conclusions The combination of IV thrombolysis and stent retriever thrombectomy with the Solitaire device is highly effective in achieving successful recanalization and a good clinical outcome throughout the entire range of CBS values.

Original languageEnglish (US)
Pages (from-to)929-932
Number of pages4
JournalJournal of NeuroInterventional Surgery
Volume9
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Thrombectomy
Stents
Stroke
Intracranial Thrombosis
Alberta
National Institutes of Health (U.S.)
Tissue Plasminogen Activator
Cohort Studies
Equipment and Supplies

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Association of clot burden score with radiographic and clinical outcomes following Solitaire stent retriever thrombectomy : Analysis of the SWIFT PRIME trial. / Mokin, Maxim; Levy, Elad I.; Siddiqui, Adnan H.; Goyal, Mayank; Nogueira, Raul G.; Yavagal, Dileep R; Pereira, Vitor M.; Saver, Jeffrey L.

In: Journal of NeuroInterventional Surgery, Vol. 9, No. 10, 01.10.2017, p. 929-932.

Research output: Contribution to journalArticle

Mokin, Maxim ; Levy, Elad I. ; Siddiqui, Adnan H. ; Goyal, Mayank ; Nogueira, Raul G. ; Yavagal, Dileep R ; Pereira, Vitor M. ; Saver, Jeffrey L. / Association of clot burden score with radiographic and clinical outcomes following Solitaire stent retriever thrombectomy : Analysis of the SWIFT PRIME trial. In: Journal of NeuroInterventional Surgery. 2017 ; Vol. 9, No. 10. pp. 929-932.
@article{ec5273587bf44784b8aacc5faa92edbe,
title = "Association of clot burden score with radiographic and clinical outcomes following Solitaire stent retriever thrombectomy: Analysis of the SWIFT PRIME trial",
abstract = "Background The clot burden score (CBS) was developed as a tool to evaluate the extent of intracranial thrombus burden in patients with anterior circulation acute ischemic stroke. CBS is based on the presence or absence of contrast opacification on CT angiography (CTA). Its value in predicting radiographic and clinical outcomes in patients given endovascular stroke therapy remains unknown. Objective To evaluate the relationship between CBS and outcomes after stent retriever thrombectomy in the interventional arm of the SWIFT PRIME trial. Methods CBS was calculated for the endovascular arm (IV tissue plasminogen activator plus Solitaire stent retriever) of SWIFT PRIME using baseline CTA. The cohort of 69 patients was divided into three groups according to their CBS values: CBS 0-5 (n=14), CBS 6-7 (n=23), and CBS 8-9 (n=32). Results The mean age of the 69 patients who formed the study cohort was 63.2-13.1 years, mean National Institutes of Health Stroke Scale score was 16.8-4.5, and 55{\%} of the patients were male. There was no difference in clinical characteristics among the three groups, except for the baseline Alberta Stroke Program Early CT Score (p=0.049). The site of proximal occlusion varied significantly among the three groups ( p0.001). Rates of successful recanalization (TICI 2b/3), complete recanalization (TICI 3 only) and of good clinical outcome at 3 months were similar among the three groups (p=0.24, p=0.35, and p=0.52, respectively). Conclusions The combination of IV thrombolysis and stent retriever thrombectomy with the Solitaire device is highly effective in achieving successful recanalization and a good clinical outcome throughout the entire range of CBS values.",
author = "Maxim Mokin and Levy, {Elad I.} and Siddiqui, {Adnan H.} and Mayank Goyal and Nogueira, {Raul G.} and Yavagal, {Dileep R} and Pereira, {Vitor M.} and Saver, {Jeffrey L.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1136/neurintsurg-2016-012631",
language = "English (US)",
volume = "9",
pages = "929--932",
journal = "Journal of NeuroInterventional Surgery",
issn = "1759-8478",
publisher = "BMJ Publishing Group",
number = "10",

}

TY - JOUR

T1 - Association of clot burden score with radiographic and clinical outcomes following Solitaire stent retriever thrombectomy

T2 - Analysis of the SWIFT PRIME trial

AU - Mokin, Maxim

AU - Levy, Elad I.

AU - Siddiqui, Adnan H.

AU - Goyal, Mayank

AU - Nogueira, Raul G.

AU - Yavagal, Dileep R

AU - Pereira, Vitor M.

AU - Saver, Jeffrey L.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Background The clot burden score (CBS) was developed as a tool to evaluate the extent of intracranial thrombus burden in patients with anterior circulation acute ischemic stroke. CBS is based on the presence or absence of contrast opacification on CT angiography (CTA). Its value in predicting radiographic and clinical outcomes in patients given endovascular stroke therapy remains unknown. Objective To evaluate the relationship between CBS and outcomes after stent retriever thrombectomy in the interventional arm of the SWIFT PRIME trial. Methods CBS was calculated for the endovascular arm (IV tissue plasminogen activator plus Solitaire stent retriever) of SWIFT PRIME using baseline CTA. The cohort of 69 patients was divided into three groups according to their CBS values: CBS 0-5 (n=14), CBS 6-7 (n=23), and CBS 8-9 (n=32). Results The mean age of the 69 patients who formed the study cohort was 63.2-13.1 years, mean National Institutes of Health Stroke Scale score was 16.8-4.5, and 55% of the patients were male. There was no difference in clinical characteristics among the three groups, except for the baseline Alberta Stroke Program Early CT Score (p=0.049). The site of proximal occlusion varied significantly among the three groups ( p0.001). Rates of successful recanalization (TICI 2b/3), complete recanalization (TICI 3 only) and of good clinical outcome at 3 months were similar among the three groups (p=0.24, p=0.35, and p=0.52, respectively). Conclusions The combination of IV thrombolysis and stent retriever thrombectomy with the Solitaire device is highly effective in achieving successful recanalization and a good clinical outcome throughout the entire range of CBS values.

AB - Background The clot burden score (CBS) was developed as a tool to evaluate the extent of intracranial thrombus burden in patients with anterior circulation acute ischemic stroke. CBS is based on the presence or absence of contrast opacification on CT angiography (CTA). Its value in predicting radiographic and clinical outcomes in patients given endovascular stroke therapy remains unknown. Objective To evaluate the relationship between CBS and outcomes after stent retriever thrombectomy in the interventional arm of the SWIFT PRIME trial. Methods CBS was calculated for the endovascular arm (IV tissue plasminogen activator plus Solitaire stent retriever) of SWIFT PRIME using baseline CTA. The cohort of 69 patients was divided into three groups according to their CBS values: CBS 0-5 (n=14), CBS 6-7 (n=23), and CBS 8-9 (n=32). Results The mean age of the 69 patients who formed the study cohort was 63.2-13.1 years, mean National Institutes of Health Stroke Scale score was 16.8-4.5, and 55% of the patients were male. There was no difference in clinical characteristics among the three groups, except for the baseline Alberta Stroke Program Early CT Score (p=0.049). The site of proximal occlusion varied significantly among the three groups ( p0.001). Rates of successful recanalization (TICI 2b/3), complete recanalization (TICI 3 only) and of good clinical outcome at 3 months were similar among the three groups (p=0.24, p=0.35, and p=0.52, respectively). Conclusions The combination of IV thrombolysis and stent retriever thrombectomy with the Solitaire device is highly effective in achieving successful recanalization and a good clinical outcome throughout the entire range of CBS values.

UR - http://www.scopus.com/inward/record.url?scp=85032456047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032456047&partnerID=8YFLogxK

U2 - 10.1136/neurintsurg-2016-012631

DO - 10.1136/neurintsurg-2016-012631

M3 - Article

VL - 9

SP - 929

EP - 932

JO - Journal of NeuroInterventional Surgery

JF - Journal of NeuroInterventional Surgery

SN - 1759-8478

IS - 10

ER -